These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Research progress of induced pluripotent stem cells in treatment of muscle atrophy]. Yao Z; Yang C; Sun G Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Mar; 45(2):147-51. PubMed ID: 27273988 [TBL] [Abstract][Full Text] [Related]
3. How far are induced pluripotent stem cells from the clinic? Li M; Chen M; Han W; Fu X Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696 [TBL] [Abstract][Full Text] [Related]
4. iPSCs, aging and age-related diseases. Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S N Biotechnol; 2014 Sep; 31(5):411-21. PubMed ID: 24784583 [TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells and their implication for regenerative medicine. Csobonyeiova M; Polak S; Koller J; Danisovic L Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593 [TBL] [Abstract][Full Text] [Related]
6. Aging in the mouse and perspectives of rejuvenation through induced pluripotent stem cells (iPSCs). Isobe K; Cheng Z; Ito S; Nishio N Results Probl Cell Differ; 2012; 55():413-27. PubMed ID: 22918818 [TBL] [Abstract][Full Text] [Related]
7. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons. Qi SD; Smith PD; Choong PF ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037 [TBL] [Abstract][Full Text] [Related]
8. [Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases]. Ito D; Yagi T; Suzuki N Brain Nerve; 2013 Mar; 65(3):283-8. PubMed ID: 23475520 [TBL] [Abstract][Full Text] [Related]
12. [Breakthrough in research on pluripotent stem cells and their application in medicine]. Valdimarsdóttir G; Richter A Laeknabladid; 2015 Dec; 101(12):581-6. PubMed ID: 26656400 [TBL] [Abstract][Full Text] [Related]
13. Versatility of Induced Pluripotent Stem Cells (iPSCs) for Improving the Knowledge on Musculoskeletal Diseases. Sanjurjo-Rodríguez C; Castro-Viñuelas R; Piñeiro-Ramil M; Rodríguez-Fernández S; Fuentes-Boquete I; Blanco FJ; Díaz-Prado S Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854405 [TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cell-derived extracellular vesicles: A novel approach for cell-free regenerative medicine. Taheri B; Soleimani M; Fekri Aval S; Esmaeili E; Bazi Z; Zarghami N J Cell Physiol; 2019 Jun; 234(6):8455-8464. PubMed ID: 30478831 [TBL] [Abstract][Full Text] [Related]
15. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons. Qi SD; Smith PD; Choong PF ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845 [TBL] [Abstract][Full Text] [Related]
16. Reprogram or reboot: small molecule approaches for the production of induced pluripotent stem cells and direct cell reprogramming. Jung DW; Kim WH; Williams DR ACS Chem Biol; 2014 Jan; 9(1):80-95. PubMed ID: 24245936 [TBL] [Abstract][Full Text] [Related]
17. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine. Anastasia L; Pelissero G; Venerando B; Tettamanti G Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332 [TBL] [Abstract][Full Text] [Related]
18. Induced pluripotent stem cells in medicine and biology. Takahashi K; Yamanaka S Development; 2013 Jun; 140(12):2457-61. PubMed ID: 23715538 [TBL] [Abstract][Full Text] [Related]
19. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells. Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837 [TBL] [Abstract][Full Text] [Related]